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Background:	 Uncertainty	 persists	 on	 the	 best	 treatment	 for	 patients	 with	 obstructive	
hydrocephalus:	endoscopic	third	ventriculostomy	(ETV)	or	ventriculoperitoneal	shunt	(VPS),	
particularly	 in	 the	 younger	 age	 groups.	 The	 author	 investigated	 and	 compared	 1-year	
outcomes	 for	 ETV	 and	 VPS	 treatment	 categories	 at	 Zewditu	 Memorial	 Hospital	 (ZMH),	
Ethiopia.	
Methods:	This	was	a	retrospective,	hospital-based	study.	The	study	reviewed	259	paediatric	
patients	 with	 hydrocephalus	 in	 whom	 VPS	 or	 ETV	 with	 or	 without	 choroid	 plexus	
cauterisation	(CPC)	was	done	as	a	primary	treatment,	between	January	2013	and	January	
2016	at	ZMH.	Patients’	medical	records,	operative	notes,	and	neural	tube	database	records	




underwent	 VPS	 placement	 rather	 than	 ETV	 had	 a	 statistically	 significant	 higher	 risk	 of	







76.9%	 at	 6	months	 postsurgery	 to	 54.7%	 at	 1	 year	 (P	 <	 0.001),	 while	 ETV	 success	 rate	
remained	 constant	 during	 the	 same	 period	 (66.7%	 and	 61.2%,	 respectively).	 Mortality	
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particularly	with	regards	to	the	effect	of	age	and	aetiology.	Reports	have	indicated	that	outcome	
is	dependent	on	age,6,7	independent	of	age,8-10	dependent	of	aetiology,8,9,11,12	or	dependent	on	both	
age	 and	 aetiology.13	 More	 recent	 evidence	 has	 supported	 the	 finding	 that	 age	 is	 the	 main	
determinant	of	outcome,	with	younger	children,	particularly	neonates,	faring	worse.5,14	




have	 shown	 that	 ETVs	 can	 work	 in	 a	 good	 percentage	 of	 children	 with	 communicating	
hydrocephalus.15,16	
Recently,	our	department	demonstrated	a	higher	success	rate	among	operations	performed	on	
patients	 with	 obstructive	 (noncommunicating)	 hydrocephalus	 (when	 the	 ventricles	 do	 not	




This	 was	 a	 retrospective	 cohort	 analysis	 of	 259	 children	 with	 obstructive	 hydrocephalus,	 in	
whom	cerebrospinal	fluid	(CSF)	diversion	was	performed	using	either	ETV	or	VPS	placement,	at	
Zewditu	Memorial	Hospital	(ZMH)	in	Addis	Ababa,	Ethiopia,	between	January	2013	and	January	
2016.	 Patients’	 medical	 records,	 operative	 notes,	 and	 spina	 bifida/hydrocephalus	 database	






ventricles;	 or	 intraoperative	 findings	 of	 haemosiderin	 or	 yellow	 deposits.	 All	 patients	 with	
obstructive	 hydrocephalus	were	 included,	while	 children	with	 nonobstructive	 aetiology	were	
excluded.	
Selection	 of	 patients	 for	 ETV	 was	 mainly	 based	 on	 computed	 tomography	 (CT)	 or	 magnetic	
resonance	 imaging	(MRI),	 as	well	 as	 intraoperative	 findings:	adequate	 size	of	 the	 foramina	of	
Monro	 and	 third	 ventricle,	 absence	 of	 prepontine	 cisternal	 fibrosis	 or	 scarring,	 and	 good	

















and	 6	 months	 of	 age	 (44.8%).	 There	 was	 a	 nearly	 equal	 distribution	 of	 male	 and	 female	
participants	(Table	1).	
Table 1: Sociodemographic characteristics of children with obstructive hydrocephalus, between 
January 2013 and January 2016 at Zewditu Memorial Hospital, Ethiopia 
Characteristic n (%) 
Treatment Modalities  
VPS n (%) ETV n (%) 
Age range (months) (0.1-168) 192 (0.2-168) 67 (0.1-132) 
Mean age (months) ± 
SD 11.36 ± 24.3 10.24 ± 23.5 14.54 ± 26.5 
Median age (months) 5 5 6 
Age categories     
 < 1 month 29 (11.2) 19 (9.9) 10 (14.9) 
 1-6 months 116 (44.8) 86 (44.8) 30 (44.8) 
 6-12 months  66 (25.8) 54 (28.1) 12 (17.9) 
 1-5 years  34 (13.1) 27 (14.1) 7 (10.4) 
 5-10 years 8 (3.1) 3 (1.6) 5 (7.5) 
 > 10 years 6 (2.3) 3 (1.6) 3 (4.5) 
Gender    
 Male 137 (52.9) 104 (54.2) 33 (49.3) 
 Female  122 (47.1) 88 (45.8) 34 (50.7) 
VPS = ventriculoperitoneal shunt; ETV = endoscopic third ventriculostomy; SD = standard deviation 
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ETV (%) VPS (%) Total 
Age     
≤ 1 year 49 (18.9) 157 (60.6) 206 (79.5) 
0.093 
> 1 year 18 (6.9) 35 (13.5) 53 (20.5) 
Cause     
MMC/Encephalocele 20 (29.9) 108 (56.2) 128 (49.2) 
< 0.001 
Postinfectious 10 (14.9) 28 (14.6) 38 (14.7) 
Dandy-Walker malformation 9 (13.4) 85 (11.2) 38 (14.7) 
Aqueductal stenosis 20 (29.9) 12 (15.1) 32 (12.4) 
Tumour 6 (9.0) 10 (5.2) 16 (6.2) 
Undetermined 2 (3.0) 5 (2.6) 7 (2.7) 
Total 67 (25.9) 192 (74.1) 259 (100.0) 
Complication     
Yes 6 (12.2) 37 (27.0) 43 
0.025 
No 46 (93.9) 100 (73.0) 146 
Infection     
Yes 3 (6.1) 37 (27.0) 40 (21.5) 
0.001 
No 46 (87.8) 100 (77.0) 146 (78.5) 
Overall death 3 (4.5) 9 (4.7) 12 (4.6) 0.62 
ETV = endoscopic third ventriculostomy; VPS = ventriculoperitoneal shunt; MMC = myelomeningocele 
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Table 3: Operative success rates by age and procedure among children with obstructive hydrocephalus 
Age 
(years) Surgery result 
n (%) within procedure 
P-value 
ETV VPS Total 
< 1/12 
Successful 3 (37.5) 7 (53.8) 10 (47.6) 
0.39 
Failed 5 (62.5) 6 (46.2%) 11 (52.4) 
1/12 - 6/12 
Successful 14 (66.7) 32 (53.3) 46 (55.4) 
0.17 
Failed 7 (33.3.) 30 (48.4) 37 (44.6) 
6/12 to 12/12 
Successful 5 (55.6) 21 (56.8) 26 (56.5) 
0.62 
Failed 4 (44.4) 16 (43.2) 20 (43.5) 
1-5 
Successful 3 (75.0) 11 (55.0) 14 (58.3) 
0.44 
Failed 1 (25.0) 9 (45.0) 10 (41.7) 
5-10 
Successful 3 (75.0) 2 (66.7) 4 (66.7) 
0.71 
Failed 1 (25.0) 1 (33.3) 2 (33.3) 
> 10  
Successful 2 (66.7) 2 (100.0) 3 (60.0) 
0.60 
Failed 1 (33.3) 0 (0.00) 2 (40.0) 
Total 
Successful 30 (61.2) 75 (54.7) 105 (56.5) 
0.27 
Failed 17 (38.8) 66 (45.3) 81 (43.5) 
Total 49 (100.0) 137 (100.0) 186 (100.0)  
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Table 4: Factors associated with complication of procedures in children with obstructive 
hydrocephalus 
Variable 
Complication – n (%) 
P-value 
Yes No Total 
Sex: Male 27 (14.5) 72 (38.7) 87 (46.8) 
0.10 
 Female 16 (8.6) 71 (38.2) 99 (53.2) 
 Total 43 (23.1) 143 (76.9) 186 (100.0)  
Age: ≤ 1 year 35 (18.8) 109 (58.6) 144 (77.4) 
0.31 
 > 1 Year 8 (4.3) 34 (18.3) 42 (22.6) 
 Total 43 (23.1) 143 (76.9) 186 (100.0)  
Procedure: ETV 6 (3.2) 43 (23.1) 49 (26.3) 
0.025 
 VPS 37 (19.9) 62 (53.8) 137 (73.7) 
 Total 43 (23.1) 143 (76.9) 186 (100.0)  
Cause: MMC/Encephalocele 25 (13.4) 67 (36.0) 92 (15.6) 
0.004 
 Postinfectious 9 (4.8) 17 (9.1) 26 (14.0) 
 Dandy-Walker malformation 2 (0.5) 20 (15.1) 12 (15.6) 
 Aqueductal stenosis 154 (1.1) 7 (10.8) 29 (15.6) 
 Tumour 3 (1.6) 10(5.4) 13 (7.0) 
 Undetermined 3 (1.6) 1 (0.5) 4 (2.2) 
Total 43 (23.1) 143 (76.9) 186 (100.0)  




most	 common	 indication	 for	VPS	 insertion	(108	patients	 [56.2%];	P	<	0.001),	while	ETV	was	
frequently	 performed	 for	 aqueductal	 stenosis	 and	MMC/EC	 (20	patients	 [29.9%]	 each).	Most	
study	participants	(n	=	206	[79.5%])	were	1	year	old	or	younger,	but	there	was	no	association	
with	age	and	the	preference	to	perform	either	ETV	or	VPS	placement	(P	=	0.093).	Children	who	
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Table 5: Factors associated with 1-year postoperative success among children with obstructive hydrocephalus 
Variable 
Outcome at 1-year postsurgery 
COR (95% CI) P-value 
Successful (%) Failed (%) 
Sex 
Male 53 (53.5) 46 (46.53) 0.89 (0.68 to 1.16) 
0.24 
Female 52 (59.8) 35 (40.2) 1.15 (0.84 to 1.57) 
Age 
≤ 1 year 78 (54.2) 66 (45.8) 0.91 (0.78 to 1.06) 
0.16 
> 1 year 27 (64.3) 15 (18.5) 1.39 (0.79 to 2.43) 
Procedure 
ETV 30 (61.2) 19 (38.8) 1.22 (0.74 to 2.00) 
0.27 
VPS  75 (54.7) 62 (45.3) 0.93 (0.79 to 1.11) 
Complication 
Yes 10 (24.4) 31 (75.6) 0.22 (0.12 to 0.42) 
< 0.001 
No 103 (69.1) 46 (30.9) 1.41 (1.18 to 1.80) 
Infection 
Yes 2 (5.0) 38 (95.0) 0.04 (0.10 to 0.16) 
< 0.001 
No 103 (70.5) 48 (29.5) 1.85 (1.50 to 2.27) 
Cause MMC/EC 53 (57.6) 39 (42.4.1)  0.60 
COR = crude odds ratio; CI = confidence interval; ETV = endoscopic third ventriculostomy; VPS = ventriculoperitoneal shunt; MMC = 










have	 died	 (from	 unknown	 causes).	 Overall	mortality	 (death	 from	 any	 cause	within	1	 year	 of	
surgery),	 was	 4.5%	 (3	 patients)	 among	 patients	who	 underwent	 ETV	 and	 4.7%	 (9	 patients)	
among	 those	 who	 underwent	 VPS	 insertion	 (P	 =	 0.62);	 the	 combined	 mortality	 for	 both	
procedures	was	4.6%	(12	patients).	
Discussion	
In	 this	 study,	 the	 average	 age	 at	 the	 time	 of	 first	 operation	 was	 similar	 to	 ages	 reported	
elsewhere5,17,18	but	lower	than	that	reported	by	Drake	et	al.,	who	reported	mean	ages	of	6.5	and	
1.6	years	for	ETV	and	VPS,	respectively,	among	North	American	and	European	randomised	trial	
participants.18	 .CNS	 infection	 has	 been	 reported	 as	 the	 most	 common	 cause	 of	 paediatric	
hydrocephalus	 in	 Uganda5;	 this	 differs	 from	Ethiopia,	where	 the	 leading	 causes	 of	 paediatric	
hydrocephalus	 have	 been	 congenital	 malformations	 (myelomeningocele	 and	
encephalocele).16,17,19-23	
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with	 worse	 outcomes	 in	 younger	 patients)24,26;	 in	 the	 present	 study,	 however,	 age	 was	 not	
significantly	associated	with	operative	success	or	failure,	in	agreement	with	other	previous	work,	
which	reported	that	failure	is	age-independent.8-10.	The	higher	risk	of	postoperative	infection	and	


























of	 complications.	 Children	 who	 underwent	 VPS	 placement	 had	 a	 significantly	 higher	 risk	 of	
postoperative	 infection	 and	 complications	 but	 similar	 likelihood	 of	 operative	 success	 and	
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